Ann Gray Mary's most recent trade in BioAtla Inc was a trade of 23,500 Common Stock done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 23,500 | 77,397 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 5,250 | - | 0 | Common Stock | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 257,832 | 257,832 | - | - | Director Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 61,202 | 61,202 | - | - | Director Stock Option (right to buy) | |
| Compass Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 53,897 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 36,490 | 36,490 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 8,574 | 8,574 | - | - | Stock Option (right to buy) | |
| Compass Therapeutics Inc | Ann Gray Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Ann Gray Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 5,995 | 37,397 | - | 0 | Common Stock | |
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 4,916 | 22,726 | - | 0 | Common Stock | |
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 12,160 | 12,160 | - | - | Common Stock Options | |
| Palisade Bio Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 5,100 | 5,100 | - | - | Restricted Stock Units | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,940 | 12,940 | - | - | Stock Option (right to buy) | |
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 5,503 | 17,810 | - | 0 | Common Stock | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 4,477 | 4,477 | - | - | Stock Option (right to buy) | |
| Compass Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Compass Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 3,868 | 3,868 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 5,077 | 5,077 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 2,953 | 12,356 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 967 | 0 | - | - | Restricted Stock Units | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 967 | 9,403 (0%) | 0% | 0 | Common Stock | |
| BioAtla Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,307 | 12,307 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 8,293 | 8,293 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 3,822 | 3,822 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 5,518 | 5,518 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,726 | 8,436 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 16,587 | 16,587 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2020 | 967 | 5,710 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Mary Ann Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2020 | 967 | 967 | - | - | Restricted Stock Units |